Nextera invited to PEGS Europe.

Oct 20, 2020 | Meet us

At the 12th annual PEGS Europe Summit, November 10th, CEO Geir Åge Løset presents Nextera’s NextCore drug discovery platform. The topic will encompass the novel way of developing drugs addressing the T-cell immunology space. Here, he will focus on Nextera’s NextCore platform for the development of TCR-like antibodies. These antibodies may prove to be important drugs towards HLA-associated targets, which can foster both cellular and protein therapies for immunological diseases. Read the abstract here: Developing Precision TCR-Like Specificities Using the NextCore Phage Display Platform.